AUTOLOGOUS LIVE CELL Trademark

Trademark Overview

On Tuesday, October 22, 2019, a trademark application was filed for AUTOLOGOUS LIVE CELL with the United States Patent and Trademark Office. The USPTO has given the AUTOLOGOUS LIVE CELL trademark a serial number of 88663141. The federal status of this trademark filing is REGISTERED as of Tuesday, August 11, 2020. This trademark is owned by Royal Biologics. The AUTOLOGOUS LIVE CELL trademark is filed in the Medical Instrument Products category with the following description:

Medical instruments and equipment for autologous biomaterial collection, processing, and therapeutic application
autologous live cell

General Information

Serial Number88663141
Word MarkAUTOLOGOUS LIVE CELL
Filing DateTuesday, October 22, 2019
Status700 - REGISTERED
Status DateTuesday, August 11, 2020
Registration Number6126653
Registration DateTuesday, August 11, 2020
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesMedical instruments and equipment for autologous biomaterial collection, processing, and therapeutic application

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateSaturday, October 26, 2019
Primary Code010
First Use Anywhere DateThursday, February 20, 2020
First Use In Commerce DateThursday, February 20, 2020

Trademark Owner History

Party NameRoyal Biologics
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressHackensack, NJ 07601
Party NameRoyal Biologics
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressHackensack, NJ 07601

Trademark Events

Event DateEvent Description
Friday, October 25, 2019NEW APPLICATION ENTERED
Saturday, October 26, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, January 28, 2020ASSIGNED TO EXAMINER
Tuesday, February 4, 2020NON-FINAL ACTION WRITTEN
Tuesday, February 4, 2020NON-FINAL ACTION E-MAILED
Tuesday, February 4, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, February 20, 2020TEAS AMENDMENT OF USE RECEIVED
Thursday, February 20, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, February 20, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, February 26, 2020ASSIGNED TO LIE
Monday, March 2, 2020USE AMENDMENT FILED
Monday, March 2, 2020AMENDMENT TO USE PROCESSING COMPLETE
Tuesday, June 9, 2020EXAMINER'S AMENDMENT ENTERED
Friday, March 27, 2020USE AMENDMENT ACCEPTED
Saturday, March 28, 2020NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Tuesday, June 9, 2020EXAMINERS AMENDMENT -WRITTEN
Tuesday, June 9, 2020EXAMINERS AMENDMENT E-MAILED
Tuesday, June 9, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, July 7, 2020LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, July 2, 2020APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Tuesday, August 11, 2020REGISTERED-SUPPLEMENTAL REGISTER
Monday, August 11, 2025COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Related Keywords

cell live autologous processing therapeutic application collection biomaterial instruments equipment medical